Search Results

You are looking at 1 - 5 of 5 items for :

  • technetium-99m sestamibi x
  • Clinical Medicine, other x
Clear All
Open access

Albena D. Botushanova, Nikolay P. Botushanov and Marianna P. Yaneva

agent for parathyroid imaging. Nucl Med Commun 1989;10(11):791-4. 14. Arbab As, Koizumi K, Toyama K, et al. Uptake of technetium-99m-tetrofosmin, technetium-99m- MIBI and thallium-201 in tumor cell lines. J Nuc Med 1996;37(10):1551-6. 15. O’Donety MJ, Kettle AG, Wells CP, et al. Parathyroid imaging with technetium-99m-sestamibi: preoperative localization and tissue uptake studies. J Nucl Med 1998;33:313-8. 16. Lee VS, Spritzer CE, Coleman RE, et al. The complementary roles of fast spin-echo MR imaging and double-phase 99

Open access

Miloš Stević, Marina Vlajković, Goran Koraćević, Radivoj Kocić, Milena Rajić and Slobodan Ilić

:1694-740 8. Iskander S, Iskandrian AE. Risk assessment using single- photon emission computed tomographic technetium-99m sestamibi imaging. J Am CollCardiol 1998; 32(1):57-62 http://dx.doi.org/10.1016/S0735-1097(98)00177-6 9. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging- executive summary: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for

Open access

Emilija Sandevska, Daniela Pop Gjorcheva, Marija Vavlukis, Aleksandar Sandevski, Irena Kafedziska, Ljubinka Krstik-Damjanovska, Venjamin Majstorov, Sasha Jovanovska-Perchinkova, Filip Guchev and Nela Kostova

–294. 22. Baharfard N, Shiroodi MK, Fotoohi F,Samangooie Sh,Asli N,Eghyesadi0Araghi P, Javadi H,Semnani Sh,Amini A,Assadi M:Myocardial perfusion imaging using a technetium-99m Sestamibi in asymptomatic and low risk for coronary artery disease patients with diagnosed systemic lupus erythematosus. Perfusion 2010, 26(2), 151–157. 23. Delcour KS, Khaja A, Chockalingam A, Kuppuswamy S, Dresser T.Outcomes in patients with abnormal myocardial perfusion imaging and normal coronary angiograms. Angiology 2009 Jun-Jul; 60(3): 318–321. 24. Alqaisi F,Albadrin F,Jaffery Z

Open access

Irena Peovska Mitevska, Jelka Davceva Pavlovska, Elizabeta Srbinovska, Marijan Bosevski, Maja Zdravkovska, Daniela Pop Gorceva and Marina Zdravevska

. De Lorenzo A, Lima RS, Siqueira-Fiho AG, Pantoja MR. Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. Am J Cardiol. 2002; 90: 827-832. 14. Zellweger MJ, Hachamovitch R, Kang X, et al. Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients. Eur Heart J. 2004; 25: 543- 550. 15. Miller TD, Rajagopalan N, Hodge DO, Frye

Open access

Zorica Naumovska, Aleksandra K. Nestorovska, Zoran Sterjev, Ana Filipce, Aleksandar Dimovski and Ljubica Suturkova

. Transplantation. 2008; 86(9): 1206-13. 54. Wong M, Evans S, Rivory LP, Hoskins JM, Mann GJ, Farlow D, et al. Hepatic technetium Tc 99mlabeled sestamibi elimination rate and ABCB1 (MDR1) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancer. Clin Pharmacol Ther. 2005; 77(1): 33-42. 55. Panczyk M, Balcerczak E, Piaskowski S, Jamroziak K, Pasz-Walczak G, Mirowski M. ABCB1 gene polymorphisms and haplotype analysis in colorectal cancer. Int J Colorectal Dis. 2009; 24(8): 895-905. 56. Sai K, Kaniwa N, Itoda M, Saito Y, Hasegawa R, Komamura K, et al